49.61CHF-1.10%Mkt Cap: 24.19B CHFP/E: 38.16Last update: 2026-05-13
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…
Industry Peers
Medical Instruments & Suppliesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)38.16
P/E (Forward)14.69
PEG1.42
P/B1.43
P/S2.31
EV/EBITDA12.45
EV/Revenue2.65
EPS (TTM)1.31
EPS (Forward)3.43
Cash Flow & Leverage
FCF Yield4.93%
FCF Margin11.21%
Operating CF2.27B CHF
CapEx (TTM)663.00M CHF
Net Debt/EBITDA1.59
Net Debt3.60B CHF
Technical
SMA 5058.75 (-15.6%)
SMA 20061.81 (-19.7%)
Beta0.70
S&P 52W Chg24.23%
Avg Vol (30d)1.39M
Avg Vol (10d)2.87M
Technical Indicators
RSI (14)24.4
MACD-3.0609
MACD Signal-2.0355
MACD Hist.-1.0254
BB Upper67.75 CHF
BB Middle57.28 CHF
BB Lower46.81 CHF
BB Width36.56%
ATR (14)1.678 CHF
Vol Ratio (20d)1.21x
52W Range
47.805% of range80.96
52W High80.96 CHF
52W Low47.80 CHF
Profitability
Gross Margin55.24%
EBITDA Margin21.30%
Profit Margin9.42%
Oper. Margin10.79%
ROE4.45%
ROA3.11%
Revenue Growth9.40%
Earnings Growth-44.60%
Balance Sheet
Debt/Equity0.02
Current Ratio2.20
Quick Ratio1.22
Book Value/Sh35.32 CHF
Cash/Share3.402 CHF
Dividends
Fwd Div Rate0.2800 CHF
Trail. Div Rate0.3530 CHF
Div. Yield0.56%
5Y Avg Yield0.30%
Payout Ratio20.39%
Ex-Div DateMay 5, 2026
Pay DateMay 15, 2025
Ownership
Shares Out.487.70M
Float486.37M
Insiders0.17%
Institutions67.23%
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)75.86 CHF
Target Range50.44 CHF – 88.81 CHF
# Analysts17
Company
Market Cap24.19B CHF
Enterprise Value28.19B CHF
Revenue (TTM)10.63B CHF
Gross Profit5.75B CHF
Net Income (TTM)980.00M CHF
Revenue/Share21.65 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees25.0K
Last Price49.61 CHF
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0432492467